Precigen’s immunotherapy will likely reduce the need for repeat surgeries in recurrent respiratory papillomatosis (RRP) patients.

US FDA approves Precigen’s Papzimeos for the treatment of adults with recurrent respiratory papillomatosis: Germantown, Maryland Monday, August 18, 2025, 17:00 Hrs [IST] Precige ...

The FDA has approved Insmed’s Brinsupri™ (brensocatib 10 mg and 25 mg tablets) as the first drug authorized to treat ...

A calm hobby quickly shifted into an unexpected challenge, proving that even soothing pastimes can surprise you.

My name is Nina and I'm a 4 month old, female, Domestic Shorthair who came to SB Humane in search of a new caring home.

Free activities aren’t just pastimes—they’re tiny rebellions against the myth that joy always comes with a price tag.

Alexander Koberidze's bizarre and wonderful "Dry Leaf" plays pixelated hide-and-seek with reality and memory across the ...

If it's time for you to stock up on your snacks, then you absolutely must head to Aldi to check out these excellent TikTok ...

Shonen Jump+, Shueisha's platform for digital-only manga, is home to some of the best, most compelling stories under the company's banner.

Fans believe that Taylor Swift will be headlining Super Bowl 2026. Take a look at some of the Easter eggs she's dropped.

High school football is back in the Big Bend. Kickoff classic week is upon the area, and the Tallahassee Democrat has you ...

The U.S. FDA has given a swift and full approval to Precigen Inc.’s gene therapy, Papzimeos (zopapogene imadenovec), for treating adults with recurrent respiratory papillomatosis (RRP), a rare and ...